|
|
|
Study Evaluating the Efficacy and Safety of GDC-0449 in Patients with Advanced Basal Cell Carinoma extended to UK |
 |
 |
 |
|
Monday, 14 September 2009 16:12 |
|
A Study Evaluating the Efficacy and Safety of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma has now been extended to the Royal Marsden NHS Foundation Trust, London, UK.
|
|
Read more...
|
|
Tuesday, 11 August 2009 19:59 |
|
The Gorlin Syndrome Group is committed to the promotion of research into the causes, effects, treatment and management of Gorlin Syndrome and the dissemination of the useful results. |
|
Last Updated on Tuesday, 11 August 2009 20:25 |
|
Read more...
|
|
|
Thursday, 23 July 2009 17:37 |
|
A recent article appeared on the BBC News website claims that researchers have "greatly improved" the effectiveness of a skin cancer treatment by adding an extra ingredient. Work is currently being carried out at the Peninsula Medical School in Truro, Cornwall. |
|
Last Updated on Tuesday, 11 August 2009 20:26 |
|
Read more...
|
|
Wednesday, 22 July 2009 14:25 |
|
The UK Dermatology Trials Network is open to anyone (medical staff and patients/carers) with an interest in dermatology research.The network was established in 2002 by Professor Hywel Williams of the University of Nottingham. |
|
Last Updated on Wednesday, 22 July 2009 22:50 |
|
Read more...
|
|
|
|
|
|
|
Page 1 of 2 |
Written and produced by Professor P A Farndon, Clinical Geneticist, Jim Costello (deceased) & Margaret Costello, unless otherwise stated.
The Gorlin Syndrome Group is a Registered Charity - No 1096361
© Gorlin Syndrome Group
Research & Surveys